Skip to content
Wenlo
Sign in
← Markets

Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc. (BCLI) — Form 10-Q: Quarterly report

10-QBCLIFiled Nov 16, 2026, 11:34 AM ET· Period Sep 30, 2026

About this filing

Brainstorm Cell Therapeutics Inc. (BCLI) filed Form 10-Q (quarterly report) with the SEC on Nov 16, 2026. A 10-Q is the company’s quarterly financial report.

Key facts

Document
10-Q

More BCLI filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.